CLASS II ONGOING Device recall · Reported 26 Nov 2025 · FDA Enforcement Report

Group B Streptococcus recalled by Meridian Bioscience

Meridian Bioscience is recalling Group B Streptococcus, distributed in 14 states. The recall was initiated on 7 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00840733102196, Lot Numbers: 480350U020, Exp. 2026-06-12
Quantity recalled109 in total

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0569-2026
FDA event ID
97787
Recalling firm
Meridian Bioscience, Cincinnati, OH
Classification
Class II
Status
Ongoing
Recall initiated
7 Oct 2025
FDA classified
19 Nov 2025
Reported
26 Nov 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

7 Oct 2025Recall initiated by company
19 Nov 2025Classified by FDA+43 days
26 Nov 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid Amplification Test Assay

Where it was distributed

US Distribution to states of: AL, CO, FL, GA, IL, MD, ME, MT, NH, NJ, OH, TN, TX and WA; and OUS (foreign) countries of: Canada, Italy, and Panama.

AlabamaColoradoFloridaGeorgiaIllinoisMarylandMaineMontanaNew HampshireNew JerseyOhioTennesseeTexasWashington

Questions about this recall

Why was it recalled?

The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.

Which lots are affected?

UDI/DI 00840733102196, Lot Numbers: 480350U020, Exp. 2026-06-12

Where was it sold?

US Distribution to states of: AL, CO, FL, GA, IL, MD, ME, MT, NH, NJ, OH, TN, TX and WA; and OUS (foreign) countries of: Canada, Italy, and Panama.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 97787

This product is part of a recall event; the main page for the event is alethia c. Difficile recalled by Meridian Bioscience.

ReportedClassRecallCompanyReasonWhere
CLASS IIalethia c. Difficile recalled by Meridian BioscienceMeridian BioscienceForeign Material14 states

More recalls from Meridian Bioscience

All 15

Other Test Kits & Diagnostics recalls

All 2,663